CG
CNST

Cutler Group’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Cutler Group’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,400
Closed -$5K – 5133
2020
Q1 		$5K Buy
+2,400
New +$83.4K ﹤0.01% 3135

Cutler Group's CNST Position: Q3 2021 in Review

Cutler Group sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 100 shares — an estimated $3K sold.

Cutler Group first reported a position in CNST in Q4 2019 and held it in 4 quarters. The position peaked at $230K in Q4 2019. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • Cutler Group reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Cutler Group sold 100 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $3K.
  • Cutler Group first reported a position in Constellation Pharmaceuticals, Inc. in Q4 2019 and held it in 4 quarters.
  • Cutler Group's Constellation Pharmaceuticals, Inc. position peaked at $230K in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Cutler Group's 13F filing for Q3 2021, filed 26 Oct 2021.